Forbes

Drugs for high cholesterol and migraine could become OTC in the U.S. But without a comprehensive behind-the-counter alternative, it’s hard to envision this happening.

Explore how AI in healthcare is already improving access and outcomes for millions through everyday consumer tools and evidence-based innovations.

The Mills family cashed out a majority stake in the family’s medical supplies firm to private equity in 2021. But the coming $50 billion IPO shows that even what they continue to hold is worth a fortune. Combined, Forbes estimates they’re worth $20 billion.

How HHS’s AI framework can help healthcare CIOs cut through complexity, build practical governance, and finally start scaling AI in real workflows.

The entire vaccine ecosystem is under threat, prompted less by data than a seeming desire to upend a system that has worked well for the American population for decades.

New sign-ups for in individual coverage under the Affordable Care Act, also known as Obamacare, lags last year’s pace.

Added scrutiny of childhood vaccines could sow doubts on their safety and effectiveness, exacerbating vaccine hesitancy, leading to preventable morbidity and mortality.

The National Institutes of Health awarded 22% fewer grants this year under the Trump administration than the 2015-2024 per year average, according to The New York Times.

Pittsburgh Steelers defensive tackle Cameron Heyward was diagnosed with asthma as a child and has had to manage it throughout his Ohio State and NFL football career.

When Mark Cuban talks about how his Cost Plus Drugs company can reduce prescription costs, his message is simple.

A physician fact checks President Trump's recent remarks on social media lauding the CDC Vaccine Advisory committee's reversal of the hepatitis B universal birth dosing.

FDA announcements and internal leaks has generated a storm of controversy about drug development and vaccines

As an infectious disease doctor and mother, these are my recommendations for how parents might think about the new CDC advisory committee Hepatitis B vaccine guidelines.

New members of the CDC vaccine advisory committee oppose newborn hepatitis B vaccines, saying they're not needed for most and they're dangerous. Data contradicts that.